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Abstract
Polycystic ovary syndrome (PCOS) is the most common endocrine abnormality in reproductive-age women, which 
is characterized by hyperandrogenism, anovulation, and polycystic ovaries. Some evidence suggested that leptin 
also causes PCOS due to its role in female reproductive system. The physiological function of leptin controls the 
balance of energy and suppresses the center of appetite. Patients with PCOS maybe underweight, normoweight, 
overweight, and obese, based on their body mass index (BMI), but obesity is a common clinical situation in PCOS. 
Obesity occurs when the level of leptin increases but cannot decrease appetite, resulting in leptin resistance. This 
study aimed to discover the connection between BMI and the level of leptin in patients with PCOS. This was a 
cross-sectional observational analytic performed in Dr. Hasan Sadikin General Hospital Bandung between April 
25 and July 10, 2018. Subjects included 46 PCOS patients who were diagnosed based on Rotterdam criteria by 
gynecology obstetricians in the hospital. Enzyme-linked immunosorbent assay (ELISA) was used to examine the 
leptin serum levels. Leptin level increased 74%, mostly in obese patients that comprised 41% of these subjects. 
Normal leptin levels was seen in 26% of patients, none of them was obese. The Spearman Rank correlation test 
showed a significant positive correlation between BMI and leptin levels (r=0.644, p=0.000). Hence, a high body 
mass index in people with PCOS positively correlates with increased leptin level. 
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Korelasi antara Indeks Massa Tubuh dan Kadar Leptin Serum 
pada Penderita Sindrom Ovarium Polikistik
Abstrak 
Sindrom Ovarium Polikistik (SOPK) merupakan kelainan endokrin pada wanita reproduktif yang ditandai oleh 
hiperandrogenisme, anovulasi, dan ovarium polikistik. Terdapat beberapa bukti bahwa leptin turut menyebabkan 
SOPK karena leptin berperan dalam sistem reproduksi wanita. Fungsi fisiologis leptin mengendalikan 
keseimbangan energi dan menekan pusat nafsu makan. Penderita SOPK dapat memiliki indeks massa tubuh 
(IMT) underweight, normoweight, overweight dan obese, namun obesitas merupakan gambaran klinis yang umum 
terjadi pada SOPK. Obesitas terjadi bila peningkatan kadar leptin, namun leptin tidak mampu bekerja menurunkan 
nafsu makan sehingga terjadi resistensi leptin. Penelitian ini bertujuan mengetahui hubungan IMT dengan kadar 
leptin pada penderita SOPK. Penelitian ini berbentuk analitik observasional dengan rancangan potong lintang dan 
dilakukan di Rumah Sakit Umum Pusat Dr. Hasan Sadikin (RSHS) Bandung pada tanggal  25 April–10 Juli 2018. 
Subjek penelitian sebanyak 46 penderita SOPK yang didiagnosis berdasar atas kriteria Rotterdam oleh klinisi 
obstetri ginekologi RSHS. Pemeriksaan kadar leptin serum mengunakan metode Enzyme-linked immunosorbent 
assay (ELISA). Kadar leptin yang meningkat 74% terbanyak  pada IMT obese 41% subjek, dan kadar leptin normal 
26% tidak ditemukan pada subjek yang IMT obese. Uji korelasi Rank Spearman menunjukkan korelasi positif kuat 
yang bermakna antara IMT dan kadar leptin (r=0,644; p=0,000). Indeks massa tubuh yang tinggi pada penderita 
SOPK berkorelasi positif dengan peningkatan kadar leptin. 
Kata kunci: Hormon leptin, indeks massa tubuh, sindrom ovarium polikistik
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Introduction
Polycystic ovary syndrome (PCOS) is an 
endocrine disorder characterized by ovarian 
dysfunction (anovulation or oligo-ovulation), 
hyperandrogenism, and multiple ovarian 
follicles. The multiple ovarian follicles occur if ovarian has follicles less than 10 mm in 
diameter with 12 or more surrounding the 
ovarian stroma. The PCOS has multifactorial 
causes including, among others, lifestyle, such as 
uncontrolled eating patterns and lack of physical 
activity; the presence of genetic predisposition 
(hereditary); and hormonal factors imbalance.1,2 
Azziz et al.3 has found that the global prevalence 
of PCOS is 5–20%. This prevalence depends on 
the criteria used to diagnose PCOS.4 Santoso et al.5 in Surabaya found a PCOS prevalence of 
4.5%, giving an overview of POCS prevalence 
data in Indonesia. In the long term, a PCOS 
patient, who is not treated and does not change 
lifestyle, can experience various complications 
such as infertility, type 2 diabetes mellitus 
(DMT 2), cardiovascular diseases, and metabolic 
syndrome. Good management and lifestyle 
modification play an important role to reduce 
the risks of long-term complications of PCOS.1
There are three criteria to diagnose PCOS: 
(1) the 1992 criteria of the National Institutes of 
Health (NIH) 1992, (2) the 2004 consensus of the 
European Society of Human Reproduction and 
Embryology (ESHRE) and the American Society 
for Reproductive Medicine (ASRM), and (3) the 
2006 criteria of the Androgen Excess Society.4 
The 2004 consensus of the European Society of 
Human Reproduction and Embryology (ESHRE) 
and the American Society for Reproductive 
Medicine (ASRM) produces a diagnosis criteria 
for polycystic syndrome ovaries, known as the 
Rotterdam criteria. Based on the Rotterdam 
criteria, PCOS diagnosis is established when 
two of the three criteria are met. For instance, 
the diagnosis procedure finds clinical and 
biochemical hyperandrogenism; oligo-ovulation 
or anovulation; and polycystic ovaries.4
Polycystic ovary syndrome can be found in 
women of reproductive age with various types of 
weights based on BMI. These include women who 
are underweight, normoweight, overweight, and 
obese. Yet, about 50–60% of PCOS sufferers are 
obese. Obesity, in addition to an increase of ob 
gene expression in the subcutaneous fat tissue, 
can also cause a disruption of leptin transport 
through the hypothalamus which, causing leptin 
resistance and hyperleptinemia.6,7
The leptin hormone is a polypeptide 
hormone produced and secreted by white 
adipose tissue that functions to transmit metabolic signals to the brain nerve tissue to 
modulate the hypothalamus-pituitary-ovary. 
Leptin resistance is associated with obesity 
and persistent hyperphagia, resulting in 
hyperinsulinemia that will then lead to insulin resistance.8,9 Hyperinsulinemia decreases the 
level of sex hormone binding globulin (SHBG) 
in the liver, leading to an increased androgen 
level in the ovary. Hyperinsulinemia, together 
with an increase of luteinizing hormone (LH), 
can increase the androgen level in ovary that 
will trigger hyperandrogenemia as a symptom of 
PCOS. 
Hyperleptinemia will affect the receptors 
in hypothalamus, causing changes in 
gonadotropine releasing hormone (GnRH) 
secretion. An increase in GnRH level may cause 
disruption of LH secretion which then causes an 
increase in ovarian androgen level.6,7 Increased 
androgens may cause hyperandrogenemia 
that inhibits follicular development and causes 
anovulation, infertility, and polycystic ovaries, 
which comprise the symptoms of PCOS.7,10 This 
study aimed to measure the correlation of serum 
leptin hormone level and body mass index (BMI) 
in patients with PCOS.
Methods
This was a cross-sectional observational analytic 
study on infertile women aged 20–39 years 
who had been diagnosed carrying PCOS based 
on the 2004 Rotterdam criteria by a specialist 
at the obstetrics and gynecology department 
of Dr. Hasan Sadikin General Hospital Bandung, 
Indonesia, during the period of April 25–July 10, 
2018. The exclusion criteria in this study were 
underlying diseases such as diabetes mellitus, 
hypertension, heart disorder, tuberculosis, 
thyroid, rheumatoid arthritis, examined by 
hemolysis serum, icteric, and lipemic. Data 
collected were subsequently analyzed using the 
Statistical Package for the Social Sciences (SPSS) 
for Windows version 24.0.
Based on the International Diabetes 
Federation, the normal serum leptin level is 
between 4.1–11.0 ng/mL. with a serum leptin 
level of  <4.1 ng/mL is considered low and a 
serum leptin level of >11.0 ng/mL is considered high.11 The body mass index (BMI) data was 
categorized based on Asia Pacific criteria: 
underweight when the BMI is <18.5 kg/m2, 
normoweight when the BMI is 18.5–22.9 kg/m2, 
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Table 1 Subject Characteristics 
Variable Number n (%)
Median 
(Range)
Age (year) 20–39 
BMI (kg/m2) 23.0 
(16.9–37.1)
Underweight    
<18.5 
1 ()
Normoweight 
18.5–22.9
22 (48)
Overweight 
23–24.9 
9 (20)
Obese ≥25 14 (30)
Leptin (ng/mL) 12.9 (7.1–19.1)
Increase 
>11.0 ng/mL
34 (74)Normal 
4.1–11.0 ng/mL
12 (26)
Change of Lifestyle
Exercise 
≥3x/week
5(54)
Aerobic 14(30)
Jogging 9(20)
Swimming 2(4)
Exercise <3x/week 7(15)
No exercise 14(30)
Table 2 Proportion of Classification of Body Mass Index and Serum Leptin Hormone Levels in 
  Women with PCOS
Classification of BMI 
(kg/m2)
Leptin (ng/mL)
pIncrease n (34)
n (%)
Leptin >11ng/mL
Normal n(12)
n (%)
Leptin ≤11 ng/mL
Underweight 0 (0.0) 1 (8) 0.01*Normoweight 13 (38) 9 (75)
Overweight 7 (21) 2 (17)Obese 14 (41) 0 (0.0)
*p<0.05= Significant
overweight when the BMI is 23.0–24.9 kg/m2, 
and obese when the BMI is ≥25 kg/m2.12 
The examination materials of the study 
consisted of serum derived from the venous blood 
of the study subjects. Sampling was performed 
using the phlebotomy procedure for examination 
of leptin level. Sample was then centrifuged at a 
speed of 1.000 g for 15 minutes until the serum 
was formed. The serum was subsequently put 
into a 200 micron plasticmicrotube and then 
stored at -80oC. Examination of leptin hormone 
level was carried out in July 2018 at the Clinical 
Pathology Laboratory of the hospital using 
sandwich micro Enzyme-linked immunosorbent 
assay (ELISA) assay. The required number of 
samples for this study was determined using 
the sample size formula of the Spearman Rank 
correlation analysis with a degree of confidence 
of 95%, requiring samples from 46 subjects. 
Ethical clearance for this study was obtained 
from the Health Research Ethics Committee of 
the Faculty of Medicine, Universitas Padjadjaran 
with the issuance of the ethical clearance number 
LB.04.01/A05/EC/125/IV/2018.
Results
The BMI classification applied in this study was 
the Asia-Pacific criteria with BMI <18.5 kg/m2 as 
underweight, 18.5–22.9 kg/m2 as normoweight, 
23.0–24.9 kg/m2 as overweight, and ≥25 kg/m2 as obese.
Normal leptin level in blood, according to the 
International Diabetes Federation (IDF), ranges 
between 4.1–11.0 ng/mL.11 
Results of the Rank Spearman correlation 
test on the correlation between leptin level and 
body mass index resulted in a strong positive 
correlation (r=0.644, p=0.000), which was 
statistically significant. A positive correlation 
means that the higher the body mass index is, the 
higher the level of leptin in PCOS subjects.Differences of body mass index  classification 
(underweight, normoweight, overweight, and 
obese) and serum leptin level in PCOS patients 
were then tested using chi square. (Table 2).
Women with obese PCOS have a higher 
level of leptin (Table 2). The state of obesity is 
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Table 3 Exercise, BMI, and Leptin Level
Variable
Body Mass Index Leptin Level
Underweight Normoweight Overweight Obese Increase Normal
Exercise ≥3x/week
Aerobic 12 2 1 7 7
Jogging 1 9 6 4
Swimming 1 1
Exercise <3x/week
Aerobic 2 1 4
Jogging 1 1 2
Swimming 1 1
No exercise 3 11 14
correlated with lifestyle changes such as starting 
to do regular exercises.
Discussion
Polycystic ovary syndrome (PCOS) is the most 
frequently encountered endocrinopathy in 
women of childbearing age.13 Various studies 
show that the prevalence of PCOS increases in 
reproductive age.14 The subjects of this study aged 
between 20–39 years. The BMI measurement 
determined the status of the weight as one 
of the risk factors for developing PCOS. The 
median body mass index of the subjects in this 
study was 23.0 (16.9–37.1 kgBW/m2) with 2% 
underweight, 48% normoweight, and 50% 
excessive weight (overweight, 20%, and obese, 
30%).
Of all subjects, 34 (74%) had an elevated 
leptin level with a median of 12.9 ng/mL (range 
7.1 ng/mL–19.1 ng/mL). As expected, the 
leptin level increases in PCOS. Therefore, a high 
level of leptin plays a role in the pathogenesis 
of hyperandrogenism in PCOS. Jalilian et al.15 
revealed that there is an association between 
elevated serum leptin levels and BMI in PCOS. 
Leptin resistance and lifestyle (uncontrolled 
diet and exercise)  can cause Leptin level to 
increase in 62% subjects who had excessive 
BMI (overweight 21% and obese 41%). Leptin 
resistance is caused by impaired leptin signal 
transduction on neurons in the hypothalamus. 
These leptin signals are protein of suppressors 
of cytokine signaling 3 (SOCS3), protein tyrosine 
phosphatase 1B (PTP1B), and receptor leptin of 
signal transducers and activator of transcription 
3 (STAT3). They are molecules known to weaken 
leptin signaling. The high leptin level due to 
leptin resistance interacts with the hypothalamic 
axis, hence causing reproduction dysfunction.16 
Leptin resistance plays a role in steroidogenesis 
in ovarian granulosa cells which contributes to 
increased androgens in ovarian theca cells.13 In 
leptin resistance, leptin level is high but non-
functioning. that the BMI remains above normal. 
Uncontrolled lifestyle factors (eating patterns 
and irregular exercise) can affect excessive BMI. 
Subjects who had excessive BMI (overweight and 
obese) in this study did not do the exercise as 
recommended i.e. more than 3 times a week with 
a duration of approximately 30 minutes. Stener-victorin et al.17 stated that light exercise such as 
brisk walking for 30 minutes with a frequency 
of 3 days a week may influence the BMI while 
Shetty et al.18 proposed that it can be achieved 
through aerobic exercise for 20–60 minutes with 
a frequency of 5 days a week for 12–24 weeks.
The study concluded that the mild-moderate 
exercise could increase fertility because it would 
increase blood flow and antioxidant status in 
women with PCOS.19 Leptin level was found to 
increase in 13 subjects with normoweight BMI 
while 9 subjects with normoweight BMI had 
a normal leptin level. This shows that leptin 
level can function physiologically in controlling 
the appetite center and energy metabolism. 
Of all subjects, 22 subjects had a normal BMI 
and 12 subjects routinely performed aerobic 
exercises, 9 subjects performed jogging, and 
1 went swimming more than 3 times a week 
and a duration of exercise of approximately 30 
minutes. The normal level of leptin hormone was 
present in two PCOS subjects with overweight 
BMI. This was achieved after changes of lifestyle, 
such as performing diet and regular exercises 
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combined with medical therapy (metformin). 
Both overweight subjects did aerobic exercise 
more than three times a week with a duration 
of approximately 30 minutes. In addition, they 
consumed metformin that can cause the leptin 
receptor of soluble OB-receptor (sOB-R) to 
decrease in the hypothalamus, reduce activity of 
cytochrome P450 17α-hydtoxylase (CYP17) in 
ovarian theca cells, and reduces steroidogenesis 
in the ovaries of the PCOS patients. Medical 
treatment with metformin can reduce body 
weight and decrease the leptin level due to the effect of metformin, i.e. inhibiting leptin 
secretion by inhibiting the signaling pathway 
of mitogen actived protein kinase (MAPK) in 
adipocytes. Additionally, this can also improve 
insulin sensitivity.9,20 
One subject who was underweight was found 
to have a normal leptin level. This subject had a 
history of reproductive issue from a mother who 
experienced difficulty to have children and her 
sister also suffers from infertility. According to 
Azziz et al., 3 PCOS sufferers who have infertile 
mothers and sisters due to PCOS have a 30–50% 
risk of suffering from PCOS.
The limitation of this study is that the data 
on lifestyle changes related to dietary factors are 
difficult to trace because subjects were unable to 
recall the portion of food consumed accurately. 
Consequently, it was difficult to evaluate BMI. 
This study also did not include normal controls, 
preventing comparison to be done between 
normal control and subjects with PCOS.
It can be concluded that in patients with 
PCOS, the higher the BMI is, the higher the level of leptin  hormone. Nevertheless, it is 
necessary to change lifestyle into a healthier one 
by, for example, incorporating regular exercise 
regimens and regulating dietary patterns by 
consuming balanced nutrition to achieve a 
normal BMI. Examination of serum leptin level 
can be considered to determine the leptin status 
of patients with PCOS as a consideration in 
deciding treatments to prevent leptin resistance.
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